XT-150

DB21756InvestigationalGene Therapies

XT-150 is a locally injectable non-viral therapy expressing IL-10v, a proprietary modified variant of IL-10. It is being developed by Xalud Therapeutics.

Code names
XT-150

What you can answer from here — as of April 23, 2025

6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of XT-150, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In